Mesoblast (MESO) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026)
Powered by 
Analysis
Mesoblast (MESO) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 14.05% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.65% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 411.50% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -3.34% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 16.78% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.66% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 19.96% |
| 10 | Mesoblast | 2.24 Bn | 2.14 Bn | - | 10.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.24% |
| Dec 31, 2025 | 4.84% |
| Jun 30, 2025 | -5.94% |
| Dec 31, 2024 | -25.92% |
| Jun 30, 2024 | -28.46% |
| Dec 31, 2023 | -28.75% |
| Jun 30, 2023 | -16.04% |
| Mar 31, 2023 | -8.93% |
| Dec 31, 2022 | 0.04% |
| Sep 30, 2022 | 22.23% |
| Jun 30, 2022 | 35.28% |
| Mar 31, 2022 | 39.57% |
| Dec 31, 2021 | 41.54% |
| Sep 30, 2021 | 39.36% |
| Jun 30, 2021 | 40.73% |
| Mar 31, 2021 | 33.26% |
| Dec 31, 2020 | 30.60% |
| Sep 30, 2020 | 11.93% |
| Jun 30, 2020 | 8.12% |
| Mar 31, 2020 | -3.00% |